Patients’ clinical, epidemiological and histopathological data.

Silva, Rafaela V. N.; Berzotti, Lucas A.; Laia, Marcella G.; Araújo, Liliane S.; Silva, Crislaine A.; Ribeiro, Karen B.; Brandão, Millena; Michelleti, Adilha M. R.; Machado, Juliana R.; Lira, Régia C. P.

doi:10.1371/journal.pone.0299353.s001

pone.0299353.s001.docx (20.36 kB)

Patients’ clinical, epidemiological and histopathological data.

journal contribution

posted on 2024-02-29, 18:39 authored by Rafaela V. N. Silva, Lucas A. Berzotti, Marcella G. Laia, Liliane S. Araújo, Crislaine A. Silva, Karen B. Ribeiro, Millena Brandão, Adilha M. R. Michelleti, Juliana R. Machado, Régia C. P. Lira

Patients’ clinical, epidemiological and histopathological data.

History

Usage metrics

Keywords

revealing marked variations renal cell carcinoma methylenetetrahydrofolate dehydrogenase 2 assessed using km higher fuhrman grades gene expression comparisons although prognostic value lower survival rates shorter overall survival lower expressions compared tumors exhibited higher div >< p mthfd2 protein pattern higher mthfd2 tended protein profile needs nn samples respectively mthfd2 protein expression rcc histological subtypes different rcc cohorts assess tumor prognosis tumor samples mthfd2 expression lower intensity free survival showing higher protein levels protein immunostaining even higher shorter recurrence larger tumors greater expression expression scores prognostic indicator prognostic factors mthfd2 tumor subtypes tumor characteristics 117 rcc transcript levels reliable biomarker plotter tool pathological data often diagnosed metastatic group histopathological diagnosis common type chrcc ).ccrcc compared advanced stages

Licence

CC BY 4.0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Patients’ clinical, epidemiological and histopathological data.

History

Usage metrics

Categories

Keywords

Licence

Exports